1876
S. Kim et al. / Bioorg. Med. Chem. Lett. 15 (2005) 1873–1876
18. Miller, O. V.; Gorman, R. R. J. Pharmacol. Exp. Ther.
1979, 210, 134.
References and notes
19. Norel, X.; Walch, L.; Labat, C.; Gascard, J. P.; Dulmet,
E.; Brink, C. Br. J. Pharmacol. 1999, 126, 867.
20. Walch, L.; Labat, C.; Gascard, J. P.; deMontpreville, V.;
Brink, C.; Norel, X. Br. J. Pharmacol. 1999, 126, 859.
21. Monneret, S.; Gravel, S.; Diamond, M.; Rokach, J.;
Powell, W. S. Blood 2001, 98, 1942.
22. Hirai, H.; Tanaka, K.; Yoshie, O.; Ogawa, K.; Kenmotsu,
K.; Takamori, Y.; Ichimasa, M.; Sugamura, K.; Naka-
mura, M.; Takano, S.; Nagata, K. J. Exp. Med. 2001, 193,
255.
23. Monneret, G.; Cossette, C.; Gravel, S.; Rokach, J.;
Powell, W. S. J. Pharmacol. Exp. Ther. 2003, 304, 349.
24. Crabbe, P.; Cervantes, A.; Meana, C. J. Chem. Soc.,
Chem. Commun. 1973, 119.
25. Mitra, A. The Synthesis of Prostaglandins; Wiley: New
York, 1977.
1. Crabbe, P. In Organic Chemistry; Blomquist, A. T.,
Wasserman, H. H., Eds.; Academic: New York, 1977;
Vol. 36, p 442.
2. Hayashi, M.; Tanouchi, T. J. Org. Chem. 1973, 38, 2115.
3. Nishizawa, E. E.; Miller, W. L.; Gorman, R. R.; Bundy,
G. L.; Svensson, J.; Hamberg, H. Prostaglandins 1975, 9,
109.
4. Jenny, E. F.; Schaublin, P. Tetrahedron Lett. 1974, 26,
2235.
5. Bindra, J. S.; Bindra, R. Prostaglandin Synthesis; Aca-
demic: New York, 1977.
6. Nicolaou, K. C.; Petasis, N. A. In CRC Handbook of
Eicosanoids: Prostaglandins and Related Lipids. Chemical
and Biochemical Aspects, Part B; Willis, A. L., Ed.; CRC:
Boca Raton, FL, 1987; Vol. I, p 1.
7. Urade, Y.; Ujihara, M.; Horiguchi, Y.; Igarashi, M.;
Nagata, A.; Ikai, K.; Hayaisha, O. J. Biol. Chem. 1990,
265, 371.
26. Yankee, E. W.; Axen, U.; Bundy, G. L. J. Am. Chem. Soc.
1974, 96, 5865.
27. Khanapure, S. P.; Manna, S.; Rokach, J.; Murphy, R. C.;
Wheelan, P.; Powell, W. S. J. Org. Chem. 1995, 60,
1806.
28. Noyori, R.; Tomino, I.; Yamada, M.; Nishizawa, M. J.
Am. Chem. Soc. 1984, 106, 6717.
8. Urade, Y.; Ujihara, M.; Horiguchi, Y.; Ikai, K.; Hayaisha,
O. J. Immunol. 1989, 143, 2982.
9. Tanaka, K.; Ogawa, K.; Sugamura, K.; Nakamura, M.;
Takano, S.; Nagata, K. J. Immunol. 2000, 164, 2277.
10. Urade, Y.; Hayaisha, O. Biochim. Biophys. Acta 2000,
1482, 259.
11. Murray, J. J.; Tonnel, A. B.; Brash, A. R.; Roberts, L. J.;
Gosset, P.; Workman, R.; Capron, A.; Oates, J. A. N.
Engl. J. Med. 1986, 315, 800.
12. Roberts, L. J.; Sweetman, B. J.; Lewis, R. A.; Austen, K.
F.; Oates, J. A. N. Engl. J. Med. 1980, 303, 1400.
13. Powell, W. S.; Gravel, S.; MacLeod, R. J.; Mills, E.;
Hashefi, M. J. Biol. Chem. 1993, 268, 9280.
14. Powell, W. S.; Chung, D.; Gravel, S. J. Immunol. 1995,
154, 4123.
29. Corey, E. J.; Bakshi, R. K.; Shibata, S.; Chen, C.-P.;
Singh, V. K. J. Am. Chem. Soc. 1987, 109, 7925.
30. The NMR data of the compound 3: H NMR (360 MHz,
1
CDCl3), d 5.6 (m, 2H), 5.45 (m, 2H), 4.55 (m, 1H), 4.18
(q, J = 13 and 6.3 Hz, 1H), 2.8 (dd, J = 12.1 and 8.5 Hz,
1H), 2.45 (m, 3H), 2.35 (t, J = 6 Hz, 2H), 2.15 (m, 3H),
1.95 (m, 1H), 1.65 (m, 4H), 1.3 (m, 6H), 0.9 (t, J = 6 Hz,
3H); 13C NMR (360 MHz, CDCl3), d 217, 175, 138.5,
131.5, 128, 127.5, 74, 68, 55, 54, 50, 48, 38, 33, 32, 26,
25.5, 25, 23, 14.
1
31. The NMR data of the compound 20: H NMR (360 MHz,
15. Khanapure, S. P.; Shi, X. X.; Powell, W. S.; Rokach, J. J.
Org. Chem. 1998, 63, 337.
16. Berhane, K.; Ray, A. A.; Khanapure, S. P.; Rokach, J.;
Powell, W. S. J. Biol. Chem. 1998, 273, 20951.
17. Narumiya, S.; Sugimoto, Y.; Ushikubi, F. Physiol. Rev.
1999, 79, 1193.
CDCl3), d 5.72 (dd, J = 15.4 and 6.4 Hz, 1H), 5.6 (dd,
J = 15.4 and 8.3 Hz, 1H), 5.45 (m, 2H), 4.15 (q, J = 15.3
and 9 Hz, 2H), 2.75 (dd, J = 18.5 and 7.5 Hz, 1H), 2.35 (m,
4H), 2.25 (m, 2H), 2.1 (m, 3H), 1.6 (m, 4H), 1.3 (m, 6H),
0.9 (t, J = 6 Hz, 3H).